Related Articles

• Association between epidermal growth factor receptor gene mutation status and short‑term efficacy of first‑line platinum‑containing chemotherapy in advanced non‑small cell lung cancer
• Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation
• Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer
• Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first‑line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis
• Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival